Answer:
It varies.
Explanation:
As gene therapy is undergoing study and research on its use by researchers on medicine (Mayo Clinic, 2017), this procedure is only used on certain patients whose disease is a type of cancer called B-cell acute lymphoblastic leukemia that affects the patient's immunity.
If the patient is a minor, I will notify and discuss it with the medical board for clearance on this procedure to gather and wait for approval from the director to prevent any failure on the procedure. As this procedure is least practiced and still lacking further studies to support wider areas in our world that requires this for a second opinion. Once a patient that is a minor has been cleared and diagnosed properly for the procedure, it will also be recorded for future references to the purpose of study and it's legal guardian will be asked if they are fine with the treatment. Same goes to adult patients (outgrown) but they usually decide themselves.
To answer the question, Once I'm cleared by the director and attained enough education and practice, I will calmly notify the patient of the treatment/procedure to them as this is an experimental and hazardous as this will modify the genetic makeup of the subject/patient.
Thank you.
